Free Trial

Tempus AI (TEM) Stock Forecast & Price Target

Tempus AI logo
$35.54 +2.51 (+7.60%)
(As of 12/20/2024 05:45 PM ET)

Tempus AI - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
9

Based on 12 Wall Street analysts who have issued ratings for Tempus AI in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 3 have given a hold rating, and 9 have given a buy rating for TEM.

Consensus Price Target

$56.00
57.57% Upside
According to the 12 analysts' twelve-month price targets for Tempus AI, the average price target is $56.00. The highest price target for TEM is $74.00, while the lowest price target for TEM is $44.00. The average price target represents a forecasted upside of 57.57% from the current price of $35.54.
Get the Latest News and Ratings for TEM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Tempus AI and its competitors.

Sign Up

TEM Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
9 Buy rating(s)
7 Buy rating(s)
9 Buy rating(s)
N/A
Hold
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$56.00$54.22$45.56N/A
Forecasted Upside57.57% Upside3.40% Upside-16.30% DownsideN/A
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
N/A

TEM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TEM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Tempus AI Stock vs. The Competition

TypeTempus AIMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.81
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside57.57% Upside25,828.93% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent TEM News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/13/2024Bank of America
3 of 5 stars
 Boost TargetNeutral ➝ Neutral$52.00 ➝ $54.00+25.44%
12/13/2024Wolfe Research
3 of 5 stars
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$60.00+42.89%
12/9/2024Guggenheim
2 of 5 stars
S. Nambi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$74.00+46.71%
11/12/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Westenberg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$40.00 ➝ $70.00-3.07%
11/11/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$45.00 ➝ $65.00-11.89%
10/15/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Schappel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$48.00 ➝ $57.00+12.38%
8/7/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$42.00 ➝ $47.00+19.84%
8/7/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Macdonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$47.00 ➝ $47.00+15.62%
7/9/2024Longbow Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$48.00+44.58%
7/9/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Brackmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
7/9/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$44.00+32.53%
7/9/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Brennan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$50.00+50.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:48 AM ET.


TEM Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Tempus AI is $56.00, with a high forecast of $74.00 and a low forecast of $44.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tempus AI in the last year. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TEM shares.

According to analysts, Tempus AI's stock has a predicted upside of 57.57% based on their 12-month stock forecasts.

Over the previous 90 days, Tempus AI's stock had 2 downgrades by analysts.

Tempus AI has been rated by research analysts at Bank of America, Guggenheim, Loop Capital, Piper Sandler, Stifel Nicolaus, and Wolfe Research in the past 90 days.

Analysts like Tempus AI less than other "medical" companies. The consensus rating score for Tempus AI is 2.75 while the average consensus rating score for "medical" companies is 2.81. Learn more on how TEM compares to other companies.


This page (NASDAQ:TEM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners